Study on preventing pneumocystis pneumonia in autoimmune disease
Treatments studied
Part of Immune system & allergy, Infections, Lungs & breathing, Skin clinical trials.
This trial tests whether a preventive treatment can stop pneumocystis pneumonia (a lung infection) in people with autoimmune inflammatory rheumatic diseases who are taking steroids or other immune-suppressing medicines. It aims to find the safest and most effective way to protect you from this serious infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have an autoimmune inflammatory rheumatic disease (like lupus, rheumatoid arthritis, or similar).
- You are currently taking steroids or other medicines that suppress your immune system.
- You are 18 years old or older.
- You have not yet received the standard preventive treatment (TMP/SMZ) for pneumocystis pneumonia.
- You do not have severe liver, kidney, or blood problems, and you do not have HIV, cancer, or an organ transplant.
- You are not pregnant, breastfeeding, or allergic to sulfa drugs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether treating a specific germ (Pneumocystis jirovecii) in the lungs can reduce the number of COPD flare-ups. If you have COPD with frequent flare-ups and this germ is found in your sputum, you may benefit.
This Phase 3 study tests whether low-dose trimethoprim-sulfamethoxazole (also called TMP-SMX) can treat Pneumocystis pneumonia (PCP) in people with weakened immune systems. It may help improve treatment while reducing side effects compared with standard dosing.
This trial tests different antibiotics for people with pneumocystis pneumonia who cannot take the standard treatment. It aims to find the best alternative therapy.
This trial tests how long kidney transplant patients should take a common antibiotic (sulfamethoxazole) to prevent a lung infection called PJP. You may join if you are between 18 and 70 and have had a kidney transplant.
This study tests whether stopping methotrexate for a short time before getting the pneumonia vaccine (PCV20) helps your body build a stronger immune response. It is for people with autoimmune rheumatic diseases like rheumatoid arthritis or lupus whose disease is under control.
This trial tests whether adding corticosteroids helps non-HIV immunocompromised adults with severe Pneumocystis pneumonia in the ICU. If you meet the criteria, you may be randomly assigned to receive either steroids plus standard care or standard care alone.
Hear when a new Autoimmune Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.